Cite

    Bitoun, S. et al. (2018). Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications. Annals of the rheumatic diseases. 77 (12), pp. 1835-1836. [Online].